Lung-Brain Axis as a Mediator of Delirium
Lung-Brain Axis as a Mediator of Delirium
批准号:
10647837
负责人:
Joseph Alan Hippensteel
金额:
$16.18万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-08-01 至 2026-06-30
关键词:
AcidsAcuteAcute Respiratory Distress SyndromeAwardBehavioral AssayBenzodiazepinesBeta-glucuronidaseBiologyBlood CirculationBlood VesselsBrainBrain regionCellsCessation of lifeChemosensitizationChondroitin ABC LyaseChondroitin Sulfate AChondroitin SulfatesCirculationClinicalConsciousCritical IllnessDataDedicationsDeliriumEarly MobilizationsElectroencephalographyElectrophysiology (science)Endothelial CellsEndotheliumEndotoxemiaExcisionExtravasationFosteringFunctional disorderFundingFutureGlycocalyxGlycosaminoglycansHeparitin SulfateHippocampusHomeostasisHumanHyperactivityHypoxemiaHypoxiaImpaired cognitionInflammatoryInterventionInvadedInvestigationInvestmentsIon ChannelKnockout MiceLaboratoriesLungMass Spectrum AnalysisMediatingMediatorModelingModificationMusNeuronsOutcomePathogenesisPatientsPenetrationPerfusionPharmaceutical PreparationsPhysiciansPhysiologyPlasmaPre-Clinical ModelPreparationPulmonary InflammationRegional PerfusionResearchRiskScientific Advances and AccomplishmentsScientistSepsisSliceSourceSulfateSurvivorsSystemTechnical ExpertiseTechniquesTimeUp-RegulationViral PneumoniaWhole OrganismWorkanalogbehavior measurementcareerclinically relevantclinically significantcohortdisabilityexperimental studyheparanasein vivoin vivo Modelinhibitorlung injurymouse modelneuronal excitabilitynovelpharmacologicreceptorresponsesuccesssugartargeted treatmenttranslational studyvascular bed
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
The Acute Respiratory Distress Syndrome (ARDS) is a common critical illness characterized by severe
hypoxemia in response to either direct (e.g. viral pneumonia) or indirect, systemic (e.g. sepsis) insults to the
lung. Most patients with ARDS will develop delirium, defined by acute, fluctuating disturbances in cognition.
Delirium during ARDS is strongly associated with poor outcomes including long-term disability and death.
Despite this clinical significance, the mechanisms responsible for delirium in ARDS remain poorly understood.
One recent scientific advance with direct relevance to delirium in ARDS is the endothelial glycocalyx, a
chondroitin sulfate (CS)-rich layer that lines the vascular lumen. The glycocalyx is degraded early in lung injury,
releasing large concentrations of CS into the bloodstream with resultant increases in hippocampal CS content,
a brain region implicated in delirium pathogenesis. Remarkably, the presence of elevated levels of highly-
sulfated CS subtypes in humans with critical illness is associated with risk of delirium. In preliminary
experiments, I observed that these same highly-sulfated CS subtypes can directly potentiate the activity of α-
amino-3-hydroxy-5-methyl-4-isoxazolepropionic
acid
receptors (AMPARs), the primary excitatory ion channel
in the brain. This activation of AMPAR activity may be biologically relevant to delirium during ARDS, as I have
observed concordant increases in neuronal excitability in the hippocampi in a lung injury model.
The work outlined in this proposal will investigate the importance of AMPAR potentiation by CS in the
pathogenesis of delirium in both direct and indirect forms of ARDS. My work seeks to 1) determine if CS is
predominantly released from the pulmonary endothelial glycocalyx during lung injury and if release is
heparanase-dependent, 2) determine if hippocampal-penetrating CS is responsible for increased AMPAR
excitability, and 3) determine whether pulmonary-endothelium derived CS contributes to the pathophysiology of
delirium in ARDS through hippocampal AMPAR potentiation. Through these investigations, I will gain expertise
in modeling of direct lung injury, isolated perfused lung preparations to isolate and assess pulmonary
physiology and pulmonary endothelial biology, ex vivo whole-cell electrophysiology and in vivo
electroencephalography in murine hippocampi, and a murine behavioral measure relevant to human delirium.
These highly-novel studies will allow me, as an early career physician-scientist, to develop a unique
expertise studying the lung-brain axis in delirium, while generating essential preliminary data for future
independent research awards (e.g. R01).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Lung-Brain Axis as a Mediator of Delirium
-
批准号:10458053
-
项目类别:
-
资助金额:$16.18万
-
财政年份:2021
-
负责人:Joseph Alan Hippensteel
-
依托单位:
Lung-Brain Axis as a Mediator of Delirium
-
批准号:10283811
-
项目类别:
-
资助金额:$16.18万
-
财政年份:2021
-
负责人:Joseph Alan Hippensteel
-
依托单位:
Endothelial Glycocalyx Degradation during Sepsis in Aging
-
批准号:10450710
-
项目类别:
-
资助金额:$15.55万
-
财政年份:2021
-
负责人:Joseph Alan Hippensteel
-
依托单位:
Endothelial Glycocalyx Degradation during Sepsis in Aging
-
批准号:10302488
-
项目类别:
-
资助金额:$15.55万
-
财政年份:2021
-
负责人:Joseph Alan Hippensteel
-
依托单位:
海外基金